E
ExpreS2ion Biotech Holding AB
STO:EXPRS2
ExpreS2ion Biotech Holding AB
STO:EXPRS2
Price:
5.94
SEK
-9.86%
Market Cap:
kr21m
Income Statement
Earnings Waterfall
ExpreS2ion Biotech Holding AB
ExpreS2ion Biotech Holding AB
Income Statement
ExpreS2ion Biotech Holding AB
ExpreS2ion Biotech Holding AB
Currency: SEK
| Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Interest Expense |
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
4
|
3
|
3
|
2
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Revenue |
10
N/A
|
10
+6%
|
10
-6%
|
8
-14%
|
9
+8%
|
9
+1%
|
9
-4%
|
9
+5%
|
11
+15%
|
12
+9%
|
14
+19%
|
13
-4%
|
13
-2%
|
13
0%
|
15
+17%
|
14
-6%
|
15
+5%
|
15
-4%
|
14
-6%
|
14
+1%
|
11
-23%
|
9
-16%
|
6
-32%
|
7
+8%
|
6
-10%
|
9
+46%
|
6
-35%
|
8
+42%
|
8
-2%
|
8
-1%
|
9
+18%
|
10
+11%
|
11
+6%
|
12
+12%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(5)
|
(5)
|
(6)
|
(8)
|
(9)
|
(4)
|
(11)
|
(8)
|
(10)
|
(18)
|
(20)
|
(21)
|
(15)
|
(18)
|
(13)
|
(18)
|
(18)
|
(6)
|
(16)
|
(13)
|
(10)
|
(4)
|
|
| Gross Profit |
8
N/A
|
8
+8%
|
8
-6%
|
6
-19%
|
7
+7%
|
6
-3%
|
6
-3%
|
6
-1%
|
8
+27%
|
9
+14%
|
10
+19%
|
10
-2%
|
8
-20%
|
8
-7%
|
9
+21%
|
7
-28%
|
6
-4%
|
10
+62%
|
3
-74%
|
6
+108%
|
1
-89%
|
(9)
N/A
|
(14)
-46%
|
(14)
-1%
|
(9)
+38%
|
(10)
-13%
|
(8)
+20%
|
(10)
-29%
|
(10)
-1%
|
2
N/A
|
(7)
N/A
|
(3)
+62%
|
1
N/A
|
9
+567%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(19)
|
(20)
|
(19)
|
(19)
|
(21)
|
(21)
|
(23)
|
(24)
|
(24)
|
(25)
|
(27)
|
(29)
|
(28)
|
(28)
|
(40)
|
(44)
|
(50)
|
(60)
|
(51)
|
(57)
|
(69)
|
(81)
|
(114)
|
(129)
|
(97)
|
(96)
|
(49)
|
(68)
|
(58)
|
(70)
|
(59)
|
(55)
|
(55)
|
(53)
|
|
| Selling, General & Administrative |
(10)
|
(10)
|
(10)
|
(11)
|
(12)
|
(12)
|
(13)
|
(14)
|
(14)
|
(14)
|
(16)
|
(16)
|
(16)
|
(16)
|
(16)
|
(17)
|
(21)
|
(24)
|
(32)
|
(39)
|
(42)
|
(45)
|
(41)
|
(44)
|
(33)
|
(43)
|
(23)
|
(31)
|
(28)
|
(27)
|
(30)
|
(28)
|
(28)
|
(27)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(10)
|
(6)
|
(18)
|
(35)
|
(71)
|
(84)
|
(62)
|
(51)
|
(25)
|
(35)
|
(29)
|
(27)
|
(24)
|
(16)
|
(14)
|
(10)
|
|
| Depreciation & Amortization |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Other Operating Expenses |
(6)
|
(7)
|
(6)
|
(7)
|
(7)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(8)
|
(9)
|
(10)
|
(21)
|
(25)
|
(26)
|
(31)
|
(7)
|
(11)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(15)
|
(4)
|
(9)
|
(11)
|
(14)
|
|
| Operating Income |
(11)
N/A
|
(12)
-3%
|
(11)
+6%
|
(13)
-22%
|
(14)
-8%
|
(15)
-5%
|
(17)
-13%
|
(18)
-6%
|
(17)
+7%
|
(16)
+4%
|
(17)
-5%
|
(19)
-13%
|
(20)
-3%
|
(21)
-5%
|
(31)
-52%
|
(38)
-21%
|
(44)
-15%
|
(49)
-13%
|
(48)
+2%
|
(51)
-6%
|
(68)
-33%
|
(91)
-34%
|
(128)
-41%
|
(143)
-12%
|
(105)
+26%
|
(106)
-1%
|
(57)
+46%
|
(78)
-36%
|
(69)
+12%
|
(68)
+1%
|
(66)
+2%
|
(57)
+14%
|
(54)
+6%
|
(44)
+18%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
(4)
|
(3)
|
(3)
|
(2)
|
1
|
1
|
1
|
2
|
1
|
1
|
(2)
|
1
|
5
|
27
|
29
|
23
|
22
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(12)
N/A
|
(12)
-3%
|
(12)
+3%
|
(14)
-19%
|
(15)
-7%
|
(17)
-13%
|
(19)
-12%
|
(20)
-8%
|
(20)
+2%
|
(18)
+8%
|
(20)
-8%
|
(21)
-5%
|
(22)
-7%
|
(24)
-9%
|
(35)
-46%
|
(41)
-18%
|
(46)
-13%
|
(51)
-10%
|
(48)
+7%
|
(50)
-6%
|
(67)
-33%
|
(88)
-32%
|
(127)
-43%
|
(142)
-12%
|
(107)
+25%
|
(100)
+7%
|
(52)
+48%
|
(50)
+3%
|
(40)
+21%
|
(45)
-12%
|
(44)
+2%
|
(57)
-30%
|
(54)
+6%
|
(44)
+17%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Tax Provision |
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
8
|
11
|
10
|
9
|
4
|
5
|
6
|
9
|
9
|
10
|
8
|
6
|
|
| Income from Continuing Operations |
(11)
|
(11)
|
(10)
|
(12)
|
(13)
|
(14)
|
(17)
|
(18)
|
(18)
|
(16)
|
(17)
|
(18)
|
(19)
|
(21)
|
(32)
|
(38)
|
(42)
|
(47)
|
(44)
|
(47)
|
(63)
|
(84)
|
(119)
|
(131)
|
(97)
|
(91)
|
(48)
|
(45)
|
(34)
|
(36)
|
(35)
|
(47)
|
(45)
|
(38)
|
|
| Net Income (Common) |
(11)
N/A
|
(11)
-3%
|
(10)
+9%
|
(12)
-22%
|
(13)
-6%
|
(14)
-14%
|
(17)
-17%
|
(18)
-7%
|
(18)
+1%
|
(16)
+10%
|
(17)
-8%
|
(18)
-5%
|
(19)
-6%
|
(21)
-10%
|
(32)
-49%
|
(38)
-19%
|
(42)
-13%
|
(47)
-11%
|
(44)
+6%
|
(47)
-6%
|
(63)
-35%
|
(84)
-34%
|
(119)
-41%
|
(131)
-11%
|
(97)
+26%
|
(91)
+5%
|
(48)
+48%
|
(45)
+5%
|
(34)
+25%
|
(36)
-6%
|
(35)
+4%
|
(47)
-36%
|
(45)
+4%
|
(38)
+16%
|
|
| EPS (Diluted) |
-1.15
N/A
|
-1.19
-3%
|
-0.96
+19%
|
-1.17
-22%
|
-1.05
+10%
|
-1.19
-13%
|
-1.32
-11%
|
-1.49
-13%
|
-1.2
+19%
|
-1.08
+10%
|
-1.18
-9%
|
-1.18
N/A
|
-1.12
+5%
|
-1.2
-7%
|
-1.04
+13%
|
-1.32
-27%
|
-1.44
-9%
|
-1.55
-8%
|
-43.7
-2 719%
|
-1.45
+97%
|
-1.85
-28%
|
-2.09
-13%
|
-107.45
-5 041%
|
-3.48
+97%
|
-1.67
+52%
|
-60.78
-3 540%
|
-31.85
+48%
|
-35.3
-11%
|
-16.19
+54%
|
-21.31
-32%
|
-13.02
+39%
|
-17.75
-36%
|
-16.99
+4%
|
-13.39
+21%
|
|
Switch to:
Switch to:
See Also
Discover More
